Anti-IL-17A 抗体 (ab9565)
Key features and details
- Rabbit polyclonal to IL-17A
- Suitable for: IHC-P, ELISA, WB
- Reacts with: Human
- Isotype: unknown
リコンビナント抗体で、ロット間での高い再現性を実現
- 異なるロット間での安定した再現性
- 容易なスケールアップ
- 評価試験による特異性の確認済み
- 倫理基準に準拠 - アニマル・フリーの生産
製品の概要
-
製品名
Anti-IL-17A antibody
IL-17A 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to IL-17A -
由来種
Rabbit -
アプリケーション
適用あり: IHC-P, ELISA, WBmore details -
種交差性
交差種: Human -
免疫原
Recombinant full length protein corresponding to Human IL-17A. Highly pure (>98%) recombinant hIL-17 (human Interleukin-17)
Database link: Q16552 -
ポジティブ･コントロール
- ウェスタン・ブロット用ポジティブコントロールRecombinant human IL-17 protein
- WB: Recombinant human IL-17A protein (ab9567).
-
特記事項
Although some customers have been successful in IHC we no longer batch test in this application.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Lyophilized:Reconstitute with 200µl of sterile water. Please note that if you receive this product in liquid form it has already been reconstituted as described and no further reconstitution is necessary. -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
Concentration information loading... -
精製度
Immunogen affinity purified -
ポリ/モノ
ポリクローナル -
アイソタイプ
unknown -
軽鎖の種類
unknown -
研究分野
関連製品
-
Compatible Secondaries
-
Positive Controls
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab9565の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| IHC-P | (2) |
Use at an assay dependent concentration. PubMed: 29390966
|
| ELISA |
Use at an assay dependent concentration.
Allows the detection of 0.2 - 0.4 ng/well of recombinant hIL-17 (assuming 100 µl/well antibody solution). |
|
| WB |
Use at an assay dependent concentration.
|
| 特記事項 |
|---|
|
IHC-P
Use at an assay dependent concentration. PubMed: 29390966 |
|
ELISA
Use at an assay dependent concentration. Allows the detection of 0.2 - 0.4 ng/well of recombinant hIL-17 (assuming 100 µl/well antibody solution). |
|
WB
Use at an assay dependent concentration. |
ターゲット情報
-
機能
Induces stromal cells to produce proinflammatory and hematopoietic cytokines. Enhances the surface expression of the intracellular adhesion molecule-1 (ICAM-1) in fibroblasts. -
組織特異性
Restricted to activated memory T-cells. -
配列類似性
Belongs to the IL-17 family. -
翻訳後修飾
Found both in glycosylated and nonglycosylated forms. -
細胞内局在
Secreted. - Information by UniProt
-
参照データベース
- Entrez Gene: 3605 Human
- Omim: 603149 Human
- SwissProt: Q16552 Human
- Unigene: 41724 Human
-
別名
- CTLA 8 antibody
- CTLA-8 antibody
- CTLA8 antibody
see all
データシートおよび資料
-
Datasheet download
参考文献 (19)
ab9565 は 19 報の論文で使用されています。
- Montanaro M et al. The Paradox Effect of Calcification in Carotid Atherosclerosis: Microcalcification is Correlated with Plaque Instability. Int J Mol Sci 22:N/A (2021). PubMed: 33401449
- Orejudo M et al. Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension. Front Pharmacol 10:1015 (2019). PubMed: 31572188
- Othman AA et al. Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-a and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid Arthritis. Clin Pharmacol Drug Dev 8:492-502 (2019). PubMed: 30156758
- Ding H et al. Upregulation of CD81 in trophoblasts induces an imbalance of Treg/Th17 cells by promoting IL-6 expression in preeclampsia. Cell Mol Immunol 16:302-312 (2019). PubMed: 30487550
- Li S et al. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res 38:6 (2019). PubMed: 30616627
